4 |
keyssat 2011
|
18 600 |
0
|
2015-11-10
|
4 |
what is sonic aml
|
139 000 |
0
|
2015-03-04
|
4 |
oncology personal statement
|
395 000 |
0
|
2014-04-24
|
4 |
personal statement oncology
|
656 000 |
-1
|
2014-03-16
|
4 |
ASP Plus
|
99 300 000 |
0
|
2015-03-24
|
5 |
free new headway plus interm
|
431 000 |
0
|
2016-01-15
|
6 |
dr. bruce arnold her2
|
2 480 |
0
|
2014-09-09
|
6 |
renata pasqualini
|
12 700 |
0
|
2014-06-11
|
6 |
dasatinib verses gleevec
|
33 200 |
28
|
2015-11-03
|
6 |
oncology personal statement sample
|
82 800 |
0
|
2014-05-18
|
6 |
drug eluting bead products
|
102 000 |
0
|
2014-01-21
|
6 |
asco ehr symposium show
|
360 000 |
6
|
2014-08-26
|
6 |
number of oncologist in united states
|
518 000 |
1
|
2014-01-21
|
6 |
Oncology India
|
4 850 000 |
32
|
2014-10-21
|
6 |
www.asco.de
|
5 220 000 |
12
|
2013-01-13
|
6 |
jane weeks
|
97 500 000 |
0
|
2014-07-26
|
7 |
atlas trial
|
13 300 000 |
6
|
2014-08-12
|
8 |
AtlasStudy
|
4 950 |
0
|
2013-10-25
|
8 |
jmen study
|
38 600 |
5
|
2015-08-25
|
8 |
datamaintenance.brain
|
168 000 |
0
|
2013-10-24
|
8 |
nccn treatment guidelines
|
243 000 |
0
|
2014-10-21
|
8 |
icon7 incorporated
|
1 850 000 |
-3
|
2014-03-28
|
9 |
abcsg 12-studie
|
4 680 |
11
|
2015-11-03
|
9 |
dr steve oday and hormone replacemnet therapy
|
22 100 |
9
|
2015-07-09
|
9 |
open ap resection hospital stay
|
227 000 |
7
|
2015-08-11
|
9 |
hyperthermia cancer treatment
|
300 000 |
0
|
2014-08-12
|
9 |
asco guidelines
|
308 000 |
4
|
2014-10-21
|
9 |
conquer programs 2012
|
1 200 000 |
0
|
2014-08-10
|
9 |
trial node
|
11 400 000 |
0
|
2014-08-13
|
9 |
jane weeks twitter
|
32 700 000 |
10
|
2014-10-02
|
10 |
nocc national center
|
14 700 |
0
|
2014-09-29
|
10 |
nexavar thyroid
|
36 100 |
0
|
2015-08-20
|
10 |
acinic cell carcinoma
|
190 000 |
23
|
2015-03-17
|
10 |
cirsisi cancer care 2010
|
2 130 000 |
2
|
2016-01-15
|
10 |
number of oncologists in us
|
8 280 000 |
-4
|
2014-03-07
|